9G8-25777-27170
3 vaccinations
6 coded responses
35 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 223 / VA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Pain in extremity, Pyrexia, Uterine dilation and curettage — Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-24
- 2021-01-29
- 2021-02-05
- 2021-02-14
- 2021-02-19
- 2021-02-26
- 2021-04-19
- 2021-07-16
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Energy increased, Therapeutic response unexpected — Feeling: Good · Site: PainMedDRA releases: 2024-11 · check-in answers available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue, Headache — Feeling: Good · Site: PainMedDRA releases: 2024-11 · check-in answers available
- 2021-10-03
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Pain in extremity — Feeling: Good · Site: PainMedDRA releases: 2024-11 · check-in answers available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-12-30
-
2022-04-05
Survey response — 6 month, dose 3MedDRA: Fatigue, Oropharyngeal pain — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 |
Free text
Release 2
Systemic reaction (other): Pain in arm, redness and swelling developed more than 36 hours after the shot. Fever I had on Saturday and early Sunday was gone by end of day Sunday. I didnt receive an SMS from VSAFE on Sunday.
Release 9
Systemic reaction (other): Higher than usual energy level in the hours following the shot.
Systemic reaction (other): Late yesterday I developed headache and extreme fatigue for several hours.
Release 10
Systemic reaction (other): Pain in arm very slight. Residual.
Systemic reaction (other): No
Release 11
Symptoms: Several months ago December I might have had mild'COVID? Sore throat, fatigue.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SRO | Energy increased | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Therapeutic response unexpected | · | · | ✓ |
| SRO | Uterine dilation and curettage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release